Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
Gregory W. Roloff(University of Chicago), George Yaghmour(University of Tennessee Health Science Center), Melhem Solh(Johns Hopkins Hospital), Rawan Faramand(Moffitt Cancer Center), Wendy Stock(University of Chicago), Joshua Sasine(Cedars-Sinai Medical Center), Simone E. Dekker(Oregon Health & Science University), Santiago Mercadal(Huntsman Cancer Institute), Divya Koura(University of California San Diego), Marlise R. Luskin(Dana-Farber Cancer Institute), Matthew P. Connor(Hospital of the University of Pennsylvania), Vinod Pullarkat(City of Hope), Akash Mukherjee(University of Arkansas Medical Center), Bijal Shah(Boston College), Naveed Ahmed(Combined Military Hospital), Marc S. Schwartz(University of California San Diego), Caspian Oliai(APLA Health), Jessica Leonard(Oregon Health & Science University), Vishal Gupta(University of California, Los Angeles), Ibrahim Aldoss(City of Hope), Noam E. Kopmar(University of Washington), Muthu Veeraputhiran(University of Arkansas Medical Center), Evan C. Chen(Dana-Farber Cancer Institute), Rasmus T. Hoeg(University of California, Davis), LaQuisa C. Hill(Baylor College of Medicine), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Ibrahim N. Muhsen, Vamsi Kota(Augusta University), Caitlin Guzowski(Northside Hospital), Veronika Bachanová(University of Minnesota), Talal Hilal(WinnMed), Chenyu Lin(Duke University), Aaron C. Logan(University of California, San Francisco), Ryan D. Cassaday(University of Washington), Minoo Battiwalla(Sarah Cannon), Sean Tracy(Broad Institute), Kaitlyn C. Dykes(University of California San Diego), Abdullah Ladha(University of Southern California), Kate Miller, Yannis K. Valtis(Brigham and Women's Hospital), Noelle V. Frey(Hospital of the University of Pennsylvania), Timothy E. O’Connor(University of Northern Iowa), Nikeshan Jeyakumar(Stanford Blood Center), Amy Zhang, Mohamed Ahmed(The University of Texas MD Anderson Cancer Center), Jae H. Park(Memorial Sloan Kettering Cancer Center), Jozal Moore(University of Rochester Medicine), Ahmed Galal(Duke University), Lori Muffly(Stanford University)
Cited by 36
Related Papers
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
|Science|2004|9.4k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k